Cancer nanomedicine: is targeting our target?

T Lammers, F Kiessling, M Ashford, W Hennink… - Nature Reviews …, 2016 - nature.com
The majority of nanomedicines in (pre) clinical trials are based on established drugs, such
as doxorubicin and paclitaxel. Does that make sense? To some extent yes, because a lot of …

[PDF][PDF] Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford, W Hennink… - academia.edu
Cancer nanomedicine: Is targeting our target? Europe PMC Funders Group Page 1 Cancer
nanomedicine: Is targeting our target? Twan Lammers1,2,3,*, Fabian Kiessling1, Marianne …

[引用][C] Cancer nanomedicine: is targeting our target?

T Lammers, F Kiessling, M Ashford… - Nature Reviews …, 2016 - ui.adsabs.harvard.edu
Cancer nanomedicine: is targeting our target? - NASA/ADS Now on home page ads icon ads
Enable full ADS view NASA/ADS Cancer nanomedicine: is targeting our target? Lammers …

[引用][C] Cancer nanomedicine: is targeting our target?

T Lammers, F Kiessling, M Ashford, W Hennink… - Nature Reviews …, 2016 - cir.nii.ac.jp

Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford… - Nature reviews …, 2016 - europepmc.org
Cancer nanomedicine: Is targeting our target? - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford… - Nature reviews …, 2016 - pubmed.ncbi.nlm.nih.gov
Cancer nanomedicine: Is targeting our target? Cancer nanomedicine: Is targeting our target? Nat
Rev Mater. 2016 Sep;1(9):16069. doi: 10.1038/natrevmats.2016.69. Epub 2016 Sep 7. Authors …

[PDF][PDF] Cancer nanomedicine: is targeting our target?

T Lammers, F Kiessling, M Ashford, W Hennink… - Nature …, 2016 - research.utwente.nl
Cancer nanomedicine: Is targeting our target? Page 1 Cancer nanomedicine: Is targeting our
target? Twan Lammers1,2,3,*, Fabian Kiessling1, Marianne Ashford4, Wim Hennink3, Daan …

[PDF][PDF] Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford, W Hennink… - ris.utwente.nl
Cancer nanomedicine: Is targeting our target? Page 1 Cancer nanomedicine: Is targeting our
target? Twan Lammers1,2,3,*, Fabian Kiessling1, Marianne Ashford4, Wim Hennink3, Daan …

[HTML][HTML] Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford… - Nature reviews …, 2016 - ncbi.nlm.nih.gov
Cancer nanomedicine: Is targeting our target? - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Cancer nanomedicine: Is targeting our target?

T Lammers, F Kiessling, M Ashford… - Nature reviews …, 2016 - europepmc.org
Cancer nanomedicine: Is targeting our target? - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …